Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|October 28, 2005
A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infectionDaniel M Forton, Joanna M Allsop, I Jane Cox, et al.
Alzheimer Disease and Associated Disorders|March 5, 2008
Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezilJames E Galvin, Barbara Cornblatt, Paul Newhouse, et al.
The International Journal of Eating Disorders|July 4, 2007
Neuropsychological study of underweight and "weight-recovered" anorexia nervosa compared with bulimia nervosa and normal controlsPeter Bosanac, Simone Kurlender, Lillian Stojanovska, et al.
Brain Injury|September 3, 2014
Atomoxetine for attention deficits following traumatic brain injury: results from a randomized controlled trialDavid L Ripley, Clare E Morey, Don Gerber, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 22, 2012
Relationship between cognition, magnetic resonance white matter hyperintensities, and cardiovascular autonomic changes in late-life depressionAkshya Vasudev, Brian K Saxby, John T OʼBrien, et al.
Journal of Hepatology|June 10, 2008
Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy studyDaniel M Forton, Gavin Hamilton, Joanna M Allsop, et al.
Innovations in Clinical Neuroscience|April 8, 2017
Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial NeedsHolly Posner, Rosie Curiel, Chris Edgar, et al.
Innovations in Clinical Neuroscience|April 8, 2017
Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease SpectrumPhilip D Harvey, Stephanie Cosentino, Rosie Curiel, et al.
Pageof 10